Riskpilot← Back to searchSign inGet full accessMycropt ApS
APSActiveCVR 40227083Kemitorvet 220Research and experimental development on natural sciences and engineering · NACE 7210Est. 20191 employeesmycropt.com
Revenue 2024
DKK 0
EBITDA margin
—
+84% vs 2023
Equity ratio
—
Financial strength
Net profit 2024
DKK -17K
+84% vs 2023
| Revenue | DKK 0 | — |
| EBITDA | DKK -17K | +84% |
| Net profit | DKK -17K | +84% |
| Total assets | DKK 0 | -100% |
| Equity | DKK 0 | -100% |
| Employees | 1 | — |
Legal name
Mycropt ApS
CVR number
40227083
Legal form
Anpartsselskab
NACE code
7210 · Research and experimental development on natural sciences and engineering
Founded
31. januar 2019
Share capital
DKK 40.000
Employees
1 (FTE)
VAT registered
Yes
Audit selected
No
Last report
2024-12-31
Financial year
January – December
Signatory rights
Selskabet tegnes af en direktør i forening med et bestyrelsesmedlem, af to bestyrelsesmedlemmer i forening eller af den samlede bestyrelse.
Company purpose
Selskabets formål er forskning og udvikling af teknologi samt produktion til optimering af proteinproduktion samt anden virksomhed, der efter bestyrelsens skøn er beslægtet hermed.
Address
Kemitorvet 220
Phone
+4521799184
Email
morten@mycropt.com
Website
mycropt.com
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|
| Revenue | 100 | 32 | 17 | -12 | 189 | 0 |
| Staff expenses | -0 | -0 | -0 | -0 | -0 | -0 |
| EBITDA | 99 | 32 | 17 | -12 | -109 | -17 |
| Depreciation & amort. | -0 | -0 | -0 | -0 | -0 | -0 |
| EBIT | 99 | 32 | 17 | -12 | -109 | -17 |
| Net financials | 0 | -0 | -1 | -1 | 0 | 0 |
| Profit before tax | 99 | 32 | 16 | -13 | -109 | -17 |
| Tax | -0 | 7 | 5 | -3 | -0 | -0 |
| Net profit | 99 | 25 | 11 | -10 | -109 | -17 |
| Item | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|
| Total assets | 99 | 136 | 150 | 128 | 16 | 0 |
| Equity | 99 | 65 | 67 | 59 | 16 | 0 |
| Long-term debt | 0 | 0 | 0 | 0 | 0 | 0 |
| Short-term debt | 0 | 71 | 82 | 69 | 0 | 0 |
| Total debt | 0 | 71 | 82 | 69 | 0 | 0 |
EBITDA margin
-1708200.0%
This company
15.8%
Market median
-10811492% vs market
20192024
Equity ratio
0.0%
This company
38.2%
Market median
-100% vs market
20192024
Return on equity
-1708200.0%
This company
18.4%
Market median
-9283796% vs market
20192024
Net profit margin
-1708200.0%
This company
8.1%
Market median
-21088989% vs market
20192024
Asset turnover
0.00×
This company
1.12×
Market median
-100% vs market
20192024
Debt / equity
-1.00×
This company
0.62×
Market median
+261% vs market
20192024
- Annual report 2024Filed via CVR / Virk · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via CVR / Virk · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via CVR / Virk · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via CVR / Virk · Period 2021-01-01 – 2021-12-31
- Annual report 2020Filed via CVR / Virk · Period 2020-01-01 – 2020-12-31
- Annual report 2019Filed via CVR / Virk · Period 2019-01-31 – 2019-12-31
| Name | Role | Member since | Age | Other directorships |
|---|---|---|---|---|
JM Founder | Founder | 2019 | — | — |
No data on file.
| Shareholder | Type | Ownership | Votes | Since |
|---|---|---|---|---|
| Individual | 25.0% | 25.0% | 2019 | |
| Individual | 25.0% | 25.0% | 2019 | |
| Individual | 25.0% | 25.0% | 2019 | |
| Individual | 20.0% | 20.0% | 2022 | |
| Individual | 5.0% | 5.0% | 2021 |
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of Mycropt ApS also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Jenny Marie Landberg | Founder | 0 companies |